Pages that link to "Q42651195"
Jump to navigation
Jump to search
The following pages link to Incidence of cancer among persons with schizophrenia and their relatives (Q42651195):
Displaying 50 items.
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24200887) (← links)
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24235017) (← links)
- Interventions for smoking cessation and reduction in individuals with schizophrenia (Q24242470) (← links)
- Tobacco use among individuals with schizophrenia: what role has the tobacco industry played? (Q24643892) (← links)
- The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders (Q24650845) (← links)
- DNA Damage and Repair in Schizophrenia and Autism: Implications for Cancer Comorbidity and Beyond (Q26743371) (← links)
- Dysfunction in the coagulation system and schizophrenia (Q28068412) (← links)
- "Selfish spermatogonial selection": a novel mechanism for the association between advanced paternal age and neurodevelopmental disorders (Q28290020) (← links)
- Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer (Q28308288) (← links)
- Cancer in patients with schizophrenia: What is the next step? (Q30249107) (← links)
- Inflammation and the two-hit hypothesis of schizophrenia (Q30422062) (← links)
- Iptakalim Preferentially Decreases Nicotine-induced Hyperlocomotion in Phencyclidine-sensitized Rats: A Potential Dual Action against Nicotine Addiction and Psychosis (Q30458043) (← links)
- Bioactive lipids in schizophrenia (Q33246888) (← links)
- Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis (Q33262112) (← links)
- Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care (Q33442059) (← links)
- Ten critical reasons for treating tobacco dependence in inpatient psychiatry (Q33750079) (← links)
- Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability (Q33766947) (← links)
- Co-morbidity of smoking in patients with psychiatric and substance use disorders (Q33942653) (← links)
- A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities (Q34052455) (← links)
- Mortality in schizophrenia: a measurable clinical endpoint (Q34183484) (← links)
- Review: Cancer and schizophrenia: is there a paradox? (Q34183508) (← links)
- Autism and cancer risk (Q34206526) (← links)
- Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings. (Q34251665) (← links)
- Substance misuse in patients with schizophrenia: epidemiology and management (Q34585142) (← links)
- The risk of cancer in patients with generalized anxiety disorder: a nationwide population-based study (Q34608546) (← links)
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (Q34623350) (← links)
- Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia (Q34631349) (← links)
- The risk of schizophrenia and child psychiatric disorders in offspring of mothers with lung cancer and other types of cancer: a Danish nationwide register study (Q35041116) (← links)
- Detection and management of comorbidity in patients with schizophrenia (Q35102472) (← links)
- Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine? (Q35141115) (← links)
- Schizophrenia, cancer and obstetric complications in an evolutionary perspective-an empirically based hypothesis (Q35144224) (← links)
- A comparative study of reliability of self report of tobacco use among patients with bipolar and somatoform disorders (Q35167735) (← links)
- Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia (Q35880018) (← links)
- A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia (Q35891345) (← links)
- Physical Health and Dual Diagnosis (Q36009165) (← links)
- Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations (Q36267882) (← links)
- Cancer risk among users of neuroleptic medication: a population-based cohort study (Q36611720) (← links)
- Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009. (Q36621051) (← links)
- Prostate cancer and schizophrenia (Q36671740) (← links)
- Health habits of patients with schizophrenia (Q36763636) (← links)
- Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden (Q36770024) (← links)
- Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation (Q36909676) (← links)
- Is schizophrenia a syndrome of accelerated aging? (Q37044422) (← links)
- Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia (Q37200473) (← links)
- Evaluation of an evidence-based tobacco treatment curriculum for psychiatry residency training programs (Q37250424) (← links)
- Designing for dissemination: development of an evidence-based tobacco treatment curriculum for psychiatry training programs (Q37252450) (← links)
- Smoking behaviour and mental health disorders--mutual influences and implications for therapy (Q37295878) (← links)
- Addressing nicotine dependence in psychodynamic psychotherapy: perspectives from residency training (Q37412824) (← links)
- Smokers with serious mental illness and requests for nicotine replacement therapy post-hospitalisation (Q37415829) (← links)
- Training in tobacco treatments in psychiatry: a national survey of psychiatry residency training directors (Q37415833) (← links)